ArticleBritish journal of haematology2015

Entinostat, a novel histone deacetylase inhibitor is active in B-cell lymphoma and enhances the anti-tumour activity of rituximab and chemotherapy agents.

Sarah Frys et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.